background image

Clinical Trials In Charlotte

Discover hundreds of clinical trials in Charlotte.
Search clinical trials in Charlotte by condition or phase.

e.g. Respiratory Diseases
CharlotteHealthy volunteers: No

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Recruiting
Phase 3

Sponsor:

United Therapeutics

Location:

Winston-Salem, Pinehurst, Greenville, Greensboroshow 73 more

Code:

NCT04708782

Conditions

Idiopathic Pulmonary Fibrosis

Interstitial Lung Disease

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Placebo

Inhaled Treprostinil

Treprostinil Ultrasonic Nebulizer

Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Recruiting
Phase 2

Sponsor:

National Cancer Institute (NCI)

Location:

Hillsborough, Chapel Hill, Birmingham, Anchorageshow 243 more

Code:

NCT04164082

Conditions

Bladder Urothelial Carcinoma In Situ

Invasive Bladder Mixed Carcinoma

Stage 0a Bladder Cancer AJCC v8

Stage 0is Bladder Cancer AJCC v8

Stage I Bladder Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Gemcitabine Hydrochloride

Pembrolizumab

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

Recruiting
Phase 1

Sponsor:

Ono Pharmaceutical Co. Ltd

Location:

Charlotte, Birmingham, Duarte, Orangeshow 7 more

Code:

NCT05079282

Conditions

Relapsed or Refractory T Cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ONO-4685

Adapting a Sepsis Transition and Recovery Program for Optimal Scale Up

Recruiting

Sponsor:

Wake Forest University Health Sciences

Location:

Charlotte

Code:

NCT05997420

Conditions

Sepsis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

STAR Program

Usual Care

A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection

Recruiting
Phase 2
Phase 3

Sponsor:

Pfizer

Location:

Charlotte, Wilmington, Salisbury, Rocky Mountshow 91 more

Code:

NCT06079320

Conditions

Respiratory Syncytial Virus Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sisunatovir

Placebo

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Recruiting
Phase 2

Sponsor:

National Cancer Institute (NCI)

Location:

Charlotte, Winston-Salem, Greenville, Durhamshow 123 more

Code:

NCT03155620

Conditions

Advanced Malignant Solid Neoplasm

Ann Arbor Stage III Non-Hodgkin Lymphoma

Ann Arbor Stage IV Non-Hodgkin Lymphoma

Histiocytic Sarcoma

Juvenile Xanthogranuloma

Eligibility Criteria

Sex: All

Age: 12 - 21

Healthy Volunteers: Not accepted

Interventions

Biopsy

Biospecimen Collection

Bone Marrow Aspiration and Biopsy

Bone Scan

Computed Tomography

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Recruiting
Phase 3

Sponsor:

Eli Lilly and Company

Location:

Winston-Salem, Statesville, Monroe, Birminghamshow 74 more

Code:

NCT04396574

Conditions

Migraine

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Lasmiditan

Harmony TPV Post-Approval Study

Recruiting

Sponsor:

Medtronic Cardiovascular

Location:

Charlotte, Durham, Birmingham, Phoenixshow 15 more

Code:

NCT05077774

Conditions

Congenital Heart Disease

Tetrology of Fallot

RVOT Anomaly

Pulmonary Regurgitation

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Harmony TPV System

Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy

Recruiting
Phase 3

Sponsor:

Atara Biotherapeutics

Location:

Charlotte, Durham, Chapel Hill, Duarteshow 27 more

Code:

NCT03394365

Conditions

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)

Solid Organ Transplant Complications

Lymphoproliferative Disorders

Allogeneic Hematopoietic Cell Transplant

Stem Cell Transplant Complications

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

tabelecleucel

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

Recruiting
Phase 3

Sponsor:

Sanofi

Location:

Charlotte, Scottsdale, Fountain Valley, Fremontshow 29 more

Code:

NCT06130566

Conditions

Dermatitis Atopic

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Amlitelimab

Placebo